Developer docs
API playgroundTry for free, no card

Search company profiles

Numantec

Full company profile

uuid02mb2bo

Namestring
Numantec
Company typeenum
Private
Founded yearint
2023
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersViadana, Italy
HQ citystring
Viadana
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
infusion medical devices, vascular access devices, medical device manufacturing, patient care equipment, medtech products
Industry2 codes
1Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
CodeHLACAPABPrimaryYes
2Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps)
CodeHLAHAIAMPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices
No data
Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Numantec Group develops, manufactures, and sells innovative infusion devices, vascular access devices, and other healthcare devices designed to improve patient care. The company operates as a global medtech manufacturer based in Viadana, Italy, with a workforce of 1001–5,000 employees.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Infusion devices
CategoryInfusion Therapy
Description

Medical devices for delivering fluids, medications, or nutrients to patients in clinical settings, designed to improve patient care outcomes. Targeted at hospitals, clinics, and healthcare providers.

2Vascular access devices
CategoryVascular Access
Description

Medical devices used to access veins or arteries for diagnostic or therapeutic purposes, intended for clinical use in patient care. Targeted at healthcare providers and clinical facilities.

3Healthcare devices
CategoryMedical Devices
Description

Additional medical/healthcare devices developed by Numantec to support patient care in hospital and clinical environments. Targeted at the broader healthcare provider market.

No data
Peers10 records
TypeBroad incumbent
Description

Global medical device leader with large franchises in vascular access (BD Vacutainer, BD Nexiva) and infusion/IV therapy. Closest direct comparison to Numantec's stated categories, though BD operates across a much broader medtech portfolio.

TypeDirect peer
Description

Major manufacturer of infusion pumps, IV sets, and vascular access devices serving hospitals and home care worldwide. Directly comparable to Numantec's infusion and vascular access focus, with a similarly strong European manufacturing footprint.

TypeDirect peer
Description

Pure-play in IV therapy, infusion pumps, and needle-free connectors after acquiring Smiths Medical. Closely matches Numantec's infusion/vascular access device positioning as a focused specialist rather than a diversified medtech conglomerate.

TypeDirect peer
Description

Specializes in infusion therapy, IV drugs, nutrition, and medical devices, including a strong infusion pump and disposables portfolio. Highly comparable business mix to Numantec's stated infusion focus.

TypeBroad incumbent
Description

Established manufacturer of IV infusion pumps, IV solutions, and related disposables used in hospitals and home infusion. Overlaps Numantec's infusion category as part of a wider hospital products and renal care portfolio.

TypeDirect peer
Description

Global medical device company with a strong vascular access franchise (Surflo, Surshield) and infusion systems. Comparable product mix and similarly significant international manufacturing footprint.

TypeDirect peer
Description

French-headquartered specialist in single-use medical devices for vascular access and neonatal/infusion applications. Closely comparable focus and European manufacturing heritage to Numantec.

TypeDirect peer
Description

Manufacturer of vascular access devices (Arrow catheters), infusion, and other interventional products. Directly comparable to Numantec's vascular access category with overlapping hospital customers.

TypeDirect peer
Description

Japan-based manufacturer of medical devices including infusion sets, IV catheters, and dialysis products. Overlaps Numantec's infusion and vascular access categories, particularly in international and emerging markets.

TypeRegional player
Description

While primarily a dialysis services and products company, Fresenius Medical Care operates a meaningful dialyzer and infusion-adjacent device business that touches Numantec's end-market and could overlap on vascular access consumables in renal care.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Numantec

Medical Devicesnumantecgroup.com

Numantec firmographics

Firmographics
Name
Numantec
Website
https://numantecgroup.com
Company type
Private
Founded year
2023
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Numantec industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)
akta.pro secondary industry
Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM)

Keywords

  • Infusion medical devices
  • Vascular access devices
  • Medical device manufacturing
  • Patient care equipment
  • Medtech products

Where Numantec is headquartered

Location

Headquarters

HQ city
Viadana
HQ country
Italy
HQ region
Europe

Markets served

Numantec business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Numantec product offering

Product offering

Core offering

Numantec Group develops, manufactures, and sells innovative infusion devices, vascular access devices, and other healthcare devices designed to improve patient care. The company operates as a global medtech manufacturer based in Viadana, Italy, with a workforce of 1001–5,000 employees.

Differentiator

Problem solved

Functional benefit

Products and services

  • Infusion devices Medical devices for delivering fluids, medications, or nutrients to patients in clinical settings, designed to improve patient care outcomes. Targeted at hospitals, clinics, and healthcare providers.
  • Vascular access devices Medical devices used to access veins or arteries for diagnostic or therapeutic purposes, intended for clinical use in patient care. Targeted at healthcare providers and clinical facilities.
  • Healthcare devices Additional medical/healthcare devices developed by Numantec to support patient care in hospital and clinical environments. Targeted at the broader healthcare provider market.

Companies that use Numantec

Customer profile

Ideal customer profiles1 record

Numantec technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Numantec competitors and assessment

Company assessment

Broad incumbents

  • Becton, Dickinson and Company (BD): Global medical device leader with large franchises in vascular access (BD Vacutainer, BD Nexiva) and infusion/IV therapy. Closest direct comparison to Numantec's stated categories, though BD operates across a much broader medtech portfolio.
  • Baxter International: Established manufacturer of IV infusion pumps, IV solutions, and related disposables used in hospitals and home infusion. Overlaps Numantec's infusion category as part of a wider hospital products and renal care portfolio.

Direct peers

  • B. Braun: Major manufacturer of infusion pumps, IV sets, and vascular access devices serving hospitals and home care worldwide. Directly comparable to Numantec's infusion and vascular access focus, with a similarly strong European manufacturing footprint.
  • ICU Medical: Pure-play in IV therapy, infusion pumps, and needle-free connectors after acquiring Smiths Medical. Closely matches Numantec's infusion/vascular access device positioning as a focused specialist rather than a diversified medtech conglomerate.
  • Fresenius Kabi: Specializes in infusion therapy, IV drugs, nutrition, and medical devices, including a strong infusion pump and disposables portfolio. Highly comparable business mix to Numantec's stated infusion focus.
  • Terumo: Global medical device company with a strong vascular access franchise (Surflo, Surshield) and infusion systems. Comparable product mix and similarly significant international manufacturing footprint.
  • Vygon: French-headquartered specialist in single-use medical devices for vascular access and neonatal/infusion applications. Closely comparable focus and European manufacturing heritage to Numantec.
  • Teleflex: Manufacturer of vascular access devices (Arrow catheters), infusion, and other interventional products. Directly comparable to Numantec's vascular access category with overlapping hospital customers.
  • Nipro: Japan-based manufacturer of medical devices including infusion sets, IV catheters, and dialysis products. Overlaps Numantec's infusion and vascular access categories, particularly in international and emerging markets.

Regional players

  • Fresenius Medical Care: While primarily a dialysis services and products company, Fresenius Medical Care operates a meaningful dialyzer and infusion-adjacent device business that touches Numantec's end-market and could overlap on vascular access consumables in renal care.

Market position

Strengths4 records

Weaknesses4 records

Key risks5 records

Key highlights4 records

Customer concentration

Numantec financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Numantec leadership team

Management profile

Number of profiles

Numantec funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Numantec M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Numantec

What does Numantec do?

Numantec Group develops, manufactures, and sells innovative infusion devices, vascular access devices, and other healthcare devices designed to improve patient care. The company operates as a global medtech manufacturer based in Viadana, Italy, with a workforce of 1001–5,000 employees.

When was Numantec founded?

Numantec was founded in 2023. It employs 1,001 to 5,000 people.

Where is Numantec based?

Numantec is headquartered in Viadana, Italy, in the Europe region.

Who are Numantec's main competitors?

Broad incumbents on record are Becton, Dickinson and Company (BD) and Baxter International. Direct peers are B. Braun, ICU Medical, Fresenius Kabi, Terumo, Vygon, Teleflex and Nipro. Fresenius Medical Care is listed as a regional player.

Does Numantec have an API?

No public API is recorded for Numantec.

What industry is Numantec in?

Numantec's product category is Medical Devices. Its primary akta.pro industry code is HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables), with a secondary code of HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ReutersGoldman Sachs Alternatives buys control of Italian medtech firm NumantecGoldman Sachs Alternatives agreed to acquire control of Italian medtech firm Numantec from White Bridge Investment. The deal, valued at around €700 million, is expected to close in the fourth quarter. Numantec, which supplies healthcare products and drug-delivery devices, is expected to expand in Europe and strengthen its U.S. presence.EuronextGoldman Sachs Alternatives buys control of Italian medtech firm NumantecGoldman Sachs Alternatives agreed to acquire control of Italian medtech firm Numantec from White Bridge Investment. The deal, valued at around €700 million, is expected to close in the fourth quarter. Numantec, employing about 600 people, will continue expanding in Europe and strengthening its U.S. presence.NumantecgroupNumantec Announces Investment from Goldman Sachs AlternativesGoldman Sachs Alternatives agreed to acquire a majority stake in Numantec from White Bridge Investments and other shareholders. The deal is expected to close in Q4 2026, subject to regulatory approvals. Numantec, a global infusion device manufacturer, will use the investment to scale its footprint and expand into new geographies.Goldman SachsNumantec announced that Goldman Sachs Alternatives has agreed to acquire a majority stakeGoldman Sachs Alternatives agreed to acquire a majority stake in Numantec from White Bridge Investments and other shareholders. The deal is expected to close in Q4 2026, subject to regulatory approvals. Numantec, a global infusion device maker, will use the investment to scale its footprint and expand into new geographies.